[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)Methanone;Raloxifene IMpurity D;Raloxifene Impurity 4(Raloxifene EP Impurity D);(4-hydroxyphenyl)-[3-(4-hydroxyphenyl)-1-benzothiophen-2-yl]methanone;Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl](4-hydroxyphenyl)-;LY88074,LY-88074;LY 88074;LY88074, 10 mM in DMSO
LY88074 is a raloxifene analog lacking the basic side chain, used in vitro to study bone binding and interactions with the collagen matrix; it exhibits reduced bone binding compared to raloxifene, and is employed to investigate the mechanisms by which selective estrogen receptor modulators influence bone mechanical properties and fracture risk.